Relationship between QT interval prolongation and structural abnormalities in cirrhotic cardiomyopathy: A change in the current paradigm.
cardiovascular disease
cirrhosis
clinical research/practice
complication: medical/metabolic
diagnostic techniques and imaging: echocardiography
liver transplantation/hepatology
translational research/science
Journal
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
ISSN: 1600-6143
Titre abrégé: Am J Transplant
Pays: United States
ID NLM: 100968638
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
revised:
04
01
2021
received:
19
10
2020
accepted:
07
01
2021
pubmed:
17
1
2021
medline:
29
6
2021
entrez:
16
1
2021
Statut:
ppublish
Résumé
It is postulated that cardiac structural abnormalities observed in cirrhotic cardiomyopathy (CCM) contribute to the electrophysiologic abnormality of QT interval (QTc) prolongation. We sought to evaluate whether QTc prolongation is associated with intrinsic abnormalities in cardiac structure and function that characterize CCM. Consecutive patients undergoing liver transplant work-up between 2010 and 2018 were included. Measures of cardiac function on stress testing including cardiac reserve and chronotropic incompetence were collected prospectively and a corrected QTc ≥ 440 ms was considered prolonged. Overall, 439 patients were included and 65.1% had a prolonged QTc. There were no differences in markers of left ventricular and atrial remodeling, or resting systolic and diastolic function across QTc groups. The proportion of patients that met the criteria for a low cardiac reserve (39.2 vs 36.6%, p = .66) or chronotropic incompetence (18.1 vs 21.3%, p = .52) was not different in those with a QTc ≥ 440 vs <440 ms. Further, there was no association between QTc prolongation and CCM by either the 2005 World College of Gastroenterology or modified 2020 Cirrhotic Cardiomyopathy Consortium criteria. QT interval prolongation was not associated with structural or functional cardiac abnormalities that characterize CCM. These findings suggest that CCM and QT interval prolongation in cirrhosis may be two separate entities with distinct pathophysiological origins.
Identifiants
pubmed: 33453141
doi: 10.1111/ajt.16500
pmc: PMC8819736
mid: NIHMS1775407
pii: S1600-6135(22)08598-7
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2240-2245Subventions
Organisme : NHLBI NIH HHS
ID : K23 HL136891
Pays : United States
Informations de copyright
© 2021 The American Society of Transplantation and the American Society of Transplant Surgeons.
Références
Gut. 2008 Feb;57(2):268-78
pubmed: 18192456
Hepatology. 2018 Nov;68(5):2008-2015
pubmed: 29672903
Transplantation. 2021 Mar 1;105(3):593-601
pubmed: 32413014
Gastroenterology. 2001 Nov;121(5):1209-18
pubmed: 11677214
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):177-86
pubmed: 24217347
Clin Transplant. 2016 Sep;30(9):986-93
pubmed: 27292629
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Eur Heart J Qual Care Clin Outcomes. 2020 Oct 1;6(4):243-253
pubmed: 32011663
Eur Heart J Cardiovasc Imaging. 2015 Mar;16(3):233-70
pubmed: 25712077
Am J Transplant. 2021 Feb;21(2):593-603
pubmed: 32530547
Nat Clin Pract Gastroenterol Hepatol. 2006 Jun;3(6):329-37
pubmed: 16741552
Hepatology. 1998 Jan;27(1):28-34
pubmed: 9425913
Liver Transpl. 2013 Jul;19(7):701-10
pubmed: 23554120
J Card Fail. 2019 Mar;25(3):166-172
pubmed: 30412734
Am J Physiol. 1997 Aug;273(2 Pt 1):G537-44
pubmed: 9277435
Liver Transpl. 2014 Nov;20(11):1306-16
pubmed: 25044256
Gut. 2001 Aug;49(2):268-75
pubmed: 11454805
Hepatology. 2020 May;71(5):1883
pubmed: 31709570
Transplantation. 2012 Sep 27;94(6):646-51
pubmed: 22918216
Hepatology. 2020 Jan;71(1):334-345
pubmed: 31342529
Hepatol Int. 2009 Mar;3(1):294-304
pubmed: 19669380
J Cardiovasc Electrophysiol. 2007 Jan;18(1):77-82
pubmed: 17229304
Int J Cardiol. 2021 Mar 1;326:158-163
pubmed: 33186663
Hepatology. 1996 May;23(5):1128-34
pubmed: 8621144
J Hepatol. 1995 Mar;22(3):326-32
pubmed: 7608484
Am J Gastroenterol. 2020 Mar;115(3):388-397
pubmed: 31738284
J Hepatol. 1997 Apr;26(4):904-12
pubmed: 9126806
Liver Int. 2003 Aug;23(4):243-8
pubmed: 12895263